| Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00290004) | Pharmacyclics LLC. | 2005-11-01 |
| Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies (NCT00275431) | Ascenta Therapeutics | 2005-11-01 |
| Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients (NCT00558961) | Jewish General Hospital | 2005-10-01 |
| Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia (NCT00275054) | German CLL Study Group | 2005-10-01 |
| Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (NCT00598624) | IRCCS San Raffaele | 2005-09-01 |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842) | Masonic Cancer Center, University of Minnesota | 2005-07-28 |
| SPC2996 in Chronic Lymphocytic Leukaemia (NCT00285103) | Santaris Pharma A/S | 2005-06-01 |
| CFAR Study in Patients With Chronic Lymphocytic Leukemia (NCT00525603) | M.D. Anderson Cancer Center | 2005-06-01 |
| Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL (NCT00319930) | Biogen | 2005-05-01 |
| Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy (NCT00108108) | Novartis Pharmaceuticals | 2005-04-01 |
| FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years (NCT00254410) | M.D. Anderson Cancer Center | 2005-03-14 |
| Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia (NCT00109356) | Novacea | 2005-03-01 |
| Unrelated Donor Stem Cell Transplantation (NCT01364363) | Scripps Health | 2005-03-01 |
| A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) (NCT00100152) | Merck Sharp & Dohme LLC | 2005-02-01 |
| Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00104858) | Fred Hutchinson Cancer Center | 2004-12-01 |
| Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00274963) | German CLL Study Group | 2004-10-01 |
| Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00100711) | Pharmacyclics LLC. | 2004-10-01 |
| A Phase I/II Study of GX15-070MS in Untreated CLL (NCT00600964) | Gemin X | 2004-09-01 |
| Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia (NCT00281892) | German CLL Study Group | 2004-09-01 |
| Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT00151736) | Cephalon | 2004-09-01 |
| A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated (NCT00233506) | University of Iowa | 2004-07-01 |
| Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00280241) | University of Pittsburgh | 2004-06-01 |
| Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT00081887) | M.D. Anderson Cancer Center | 2004-05-01 |
| Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT00193518) | SCRI Development Innovations, LLC | 2004-04-01 |
| Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT00103558) | Biogen | 2004-03-01 |
| Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline (NCT00794820) | M.D. Anderson Cancer Center | 2003-12-01 |
| Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. (NCT00145652) | Sundsvall Hospital | 2003-12-01 |
| Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia (NCT00634881) | German CLL Study Group | 2003-11-01 |
| Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia (NCT00078234) | Genta Incorporated | 2003-11-01 |
| Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer (NCT00898079) | Children's Oncology Group | 2003-10-13 |
| Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00262795) | German CLL Study Group | 2003-09-01 |
| Oral Valganciclovir Versus Valacyclovir (NCT00562770) | M.D. Anderson Cancer Center | 2003-09-01 |
| FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients (NCT00090051) | Hoffmann-La Roche | 2003-07-31 |
| Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00096161) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) (NCT00309881) | German CLL Study Group | 2003-04-01 |
| Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients (NCT00058656) | Xcyte Therapies | 2003-03-01 |
| Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (NCT00060424) | Fred Hutchinson Cancer Center | 2003-03-01 |
| Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia (NCT00337519) | Charite University, Berlin, Germany | 2003-01-01 |
| Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. (NCT00131313) | East Valley Hematology and Oncology Medical Group | 2003-01-01 |
| Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT01082939) | M.D. Anderson Cancer Center | 2002-12-01 |
| Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia (NCT00102661) | M.D. Anderson Cancer Center | 2002-10-01 |
| Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders (NCT00071396) | M.D. Anderson Cancer Center | 2002-10-01 |
| Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT00201682) | John Byrd | 2002-10-01 |
| Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00046488) | Biogen | 2002-09-01 |
| Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer (NCT00039676) | National Cancer Institute (NCI) | 2002-07-08 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00683046) | University of Chicago | 2001-11-01 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175) | University of California, San Francisco | 2001-10-01 |
| Nonmyeloablative Allogeneic Transplant (NCT01272817) | Scripps Health | 2001-10-01 |
| Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL) (NCT01423032) | WiSP Wissenschaftlicher Service Pharma GmbH | 2001-09-01 |
| Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia (NCT00022971) | National Cancer Institute (NCI) | 2001-08-15 |
| Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma (NCT00772811) | Cooperative Study Group A for Hematology | 2001-07-01 |
| Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia (NCT00276809) | German CLL Study Group | 2001-06-01 |
| Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water (NCT01110850) | Northwell Health | 2001-06-01 |
| The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen (NCT01890486) | Wake Forest University Health Sciences | 2001-05-21 |
| A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT00073489) | Astellas Pharma Inc | 2001-05-01 |
| Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS (NCT00038831) | M.D. Anderson Cancer Center | 2001-05-01 |
| CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation (NCT00038818) | M.D. Anderson Cancer Center | 2001-05-01 |
| Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia (NCT00931645) | University Hospital, Caen | 2001-04-01 |
| Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia (NCT00021749) | Genta Incorporated | 2001-01-01 |
| Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant (NCT00571662) | University of Nebraska | 2000-12-08 |
| Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia (NCT00281983) | German CLL Study Group | 2000-06-01 |
| Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy (NCT00183950) | University of Southern California | 2000-03-01 |
| B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression (NCT01030913) | Northwell Health | 1999-12-01 |
| Understanding Chronic Lymphocytic Leukemia (NCT04028531) | Dana-Farber Cancer Institute | 1999-09-29 |
| Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants (NCT00001830) | National Cancer Institute (NCI) | 1999-07-20 |
| Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT00416910) | German CLL Study Group | 1999-07-01 |
| Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia (NCT00276848) | German CLL Study Group | 1999-07-01 |
| Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia (NCT00022880) | Corixa Corporation | 1999-07-01 |
| The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers (NCT00001873) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-02-22 |
| B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging (NCT01028430) | Northwell Health | 1998-07-01 |
| Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel (NCT00159003) | Deborah Rund | 1998-01-01 |
| Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia (NCT00275015) | German CLL Study Group | 1998-01-01 |
| Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults (NCT00001637) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-09-29 |
| Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis (NCT00001586) | National Cancer Institute (NCI) | 1997-09-01 |
| Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia (NCT00262782) | German CLL Study Group | 1997-04-01 |
| Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) (NCT00086203) | Point Therapeutics | |
| Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies (NCT00036023) | Amgen | |